Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment.

CONCLUSION: Women were more likely than men to use opioids during the course of the buprenorphine/naloxone clinical trial, and medical issues predicted opioid use during treatment for women but not men. Complementary treatment for medical problems during opioid replacement therapy may benefit women. PMID: 29672167 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29672167?dopt=Abstract

Source: The American Journal of Drug and Alcohol Abuse - April 19, 2018 Category: Addiction Authors: Barbosa-Leiker C, McPherson S, Layton ME, Burduli E, Roll JM, Ling W Tags: Am J Drug Alcohol Abuse Source Type: research